{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:59:55Z","timestamp":1762541995165},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/iop.0b013e318224ae9b","type":"journal-article","created":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T13:00:48Z","timestamp":1311339648000},"page":"1-3","source":"Crossref","is-referenced-by-count":12,"title":["Topical Diclofenac Gel for the Management of Periocular Actinic Keratosis"],"prefix":"10.1097","volume":"28","author":[{"given":"Ruchika","family":"Batra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathya","family":"Sundararajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soupramanien","family":"Sandramouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2000.103339","article-title":"The risk of progression to invasive disease.","volume":"42","author":"Glogau","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R2-1-20210129","first-page":"401","article-title":". Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0 diclofenac sodium topical gel (Solaraze).","volume":"3","author":"Nelson","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"R3-1-20210129","first-page":"156","article-title":"Bilateral comparison of the efficacy and tolerability of 3 diclofenac sodium gel and 5 5-fluorouracil cream in the treatment of actinic keratosis of the face and scalp.","volume":"5","author":"Smith","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.07856.x","article-title":". The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs).","volume":"156","author":"Fecker","year":"2007","journal-title":"Br J Dermatol"},{"key":"R5-1-20210129","first-page":"133","article-title":"The effect of hyaluronan on the in vitro deposition of diclofenac within the skin.","volume":"17","author":"Brown","year":"1995","journal-title":"Int J Tissue React"},{"key":"R6-1-20210129","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-4362.2001.01324.x","article-title":"Topical 2.0 diclofenac in 2.5 hyaluronan gel in the treatment of actinic keratoses.","volume":"40","author":"Wolf","year":"2001","journal-title":"Int J Dermatol"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1365-2133.2002.04561.x","article-title":". Topical treatment of actinic keratoses with 3.0 diclofenac in 2.5 hyaluronan gel.","volume":"146","author":"Rivers","year":"2002","journal-title":"Br J Dermatol"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1440-0960.2002.00635.x","article-title":"Topical diclofenac in hyaluronan gel for the treatment of solar keratoses.","volume":"44","author":"Gebauer","year":"2003","journal-title":"Austr J Dermatol"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00403-005-0601-9","article-title":"Three percent diclofenac in 2.5 hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies.","volume":"297","author":"Pirard","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-0536.2002.470308_11.x","article-title":"Allergic contact dermatitis from topical diclofenac in Solaraze gel.","volume":"47","author":"Kerr","year":"2002","journal-title":"Contact Dermatitis"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2133.2007.07858.x","article-title":"Genetically determined susceptibility to COX-2 inhibitors: a report of exaggerated responders to diclofenac 3 gel in the treatment of actinic keratoses.","volume":"156","author":"Patel","year":"2007","journal-title":"Br J Dermatol"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2133.2007.07864.x","article-title":". Treatment of multiple actinic keratoses with topical diclofenac 3 gel in organ transplant recipients: a series of six cases.","volume":"156","author":"Ulrich","year":"2007","journal-title":"Br J Dermatol"}],"container-title":["Ophthalmic Plastic & Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0b013e318224ae9b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:48:19Z","timestamp":1620956899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002341-201201000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0b013e318224ae9b","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}